Min Xiao

Prof. Dr. Min Xiao

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Journal of Controlled Release
Verified
Journal Article
Closed access
YLYinping Li
Yinping Li
WHWeiying Hong
Weiying Hong
HZHenan Zhang
Henan Zhang
TZTian Tian Zhang
Tian Tian Zhang
ZCZhiyong Chen
Zhiyong Chen
LXLi Xu
Li Xu

19 February 2019 in Journal of Materials Chemistry B
Verified
Journal Article
Closed access
PDF file
TZTiantian Zhang
Tiantian Zhang
YLYinping Li
Yinping Li
WHWeiying Hong
Weiying Hong
ZCZhiyong Chen
Zhiyong Chen
PPPeng Peng
Peng Peng
LXLi Xu
Li Xu
Cancer cells possess some inherent characteristics, such as glucose-dependence and intolerance to heat and exogenous reactive oxygen species (ROS). In this study, a strategy has been developed to target these vulnerable weaknesses of cancer cells using glucose oxidase (GOx) and polydopamine (PDA) functionalized iron oxide nanoparticles (Fe3O4@PDA/GOx NPs). PDA is first deposited on the surfaces of iron oxide NPs through self-polymerization, and then GOx is covalently linked with PDA upon mixing the enzyme and Fe3O4@PDA under alkaline conditions. In this system, the PDA layer along with iron oxide NPs serves as a photothermal transfer material converting near infrared (NIR) radiation into heat. The covalently linked GOx can competitively consume glucose and spontaneously generate ROS H2O2 that can be further converted by the iron oxide NPs into more toxic ˙OH, inducing apoptosis of cancer cells. The selective toxicity of Fe3O4@PDA/GOx NPs on cancer cells is demonstrated both in vitro and in vivo. In particular, a single injection rather than multiple doses results in significant suppression of tumors, and does not induce apparent histological lesions in the 4T1 tumor-bearing Balb/c mice. The versatility of the functionalization strategy reported in this study will contribute to developing efficient therapies for selective cancer treatment.

1 September 2016 in International Immunopharmacology
Verified
Journal Article
Closed access
YYYinli Yang
Yinli Yang
QHQiuju Han
Qiuju Han
CZCai Zhang
Cai Zhang
MXMin Xiao
Min Xiao
JZJian Zhang
Jian Zhang

1 August 2008 in FEMS Microbiology Letters
Verified
Journal Article
Open access
PDF file
HZHan Zhao
Han Zhao
LLLili Lu
Lili Lu
MXMin Xiao
Min Xiao
QWQinpeng Wang
Qinpeng Wang
YLYu Lu
Yu Lu
KYKenji Yamamoto
Kenji Yamamoto
A novel α-galactosidase gene (aga2) was cloned from Bifidobacterium breve 203. It contained an ORF of 2226-bp nucleotides encoding 741 amino acids wit

15 September 2016 in Applied and Environmental Microbiology
Verified
Journal Article
Closed access
PDF file
XCXiaodi Chen
Xiaodi Chen
LXLi Xu
Li Xu
LJLan Jin
Lan Jin
BSBin Sun
Bin Sun
GGGuofeng Gu
Guofeng Gu
MXMin Xiao
Min Xiao
β- N -Acetylhexosaminidases have attracted interest particularly for oligosaccharide synthesis, but their use remains limited by the rarity of enzyme sources , low efficiency, and relaxed regioselectivity of transglycosylation. In this work, genes of 13 β- N -acetylhexosaminidases, including 5 from Bacteroides fragilis ATCC 25285, 5 from Clostridium perfringens ATCC 13124, and 3 from Bifidobacterium bifidum JCM 1254, were cloned and heterogeneously expressed in Escherichia coli . The resulting recombinant enzymes were purified and screened for transglycosylation activity. A β- N -acetylhexosaminidase named BbhI, which belongs to glycoside hydrolase family 20 and was obtained from B. bifidum JCM 1254, possesses the bifunctional property of efficiently transferring both GalNAc and GlcNAc residues through β1-3 linkage to the Gal residue of lactose. The effects of initial substrate concentration, pH, temperature, and reaction time on transglycosylation activities of BbhI were studied in detail. With the use of 10 mM p NP-β-GalNAc or 20 mM p NP-β-GlcNAc as the donor and 400 mM lactose as the acceptor in phosphate buffer (pH 5.8), BbhI synthesized GalNAcβ1-3Galβ1-4Glc and GlcNAcβ1-3Galβ1-4Glc at maximal yields of 55.4% at 45°C and 4 h and 44.9% at 55°C and 1.5 h, respectively. The model docking of BbhI with lactose showed the possible molecular basis of strict regioselectivity of β1-3 linkage in β- N -acetylhexosaminyl lactose synthesis. IMPORTANCE Oligosaccharides play a crucial role in many biological events and therefore are promising potential therapeutic agents. However, their use is limited because large-scale production of oligosaccharides is difficult. The chemical synthesis requires multiple protecting group manipulations to control the regio- and stereoselectivity of glycosidic bonds. In comparison, enzymatic synthesis can produce oligosaccharides in one step by using glycosyltransferases and glycosidases. Given the lower price of their glycosyl donor and their broader acceptor specificity, glycosidases are more advantageous than glycosyltransferases for large-scale synthesis. β- N -Acetylhexosaminidases have attracted interest particularly for β- N -acetylhexosaminyl oligosaccharide synthesis, but their application is affected by having few enzyme sources, low efficiency, and relaxed regioselectivity of transglycosylation. In this work, we describe a microbial β- N -acetylhexosaminidase that exhibited strong transglycosylation activity and strict regioselectivity for β- N -acetylhexosaminyl lactose synthesis and thus provides a powerful synthetic tool to obtain biologically important GalNAcβ1-3Lac and GlcNAcβ1-3Lac.

1 July 2018 in Applied and Environmental Microbiology
Verified
Journal Article
Closed access
PDF file
LGLongcheng Guo
Longcheng Guo
XCXiaodi Chen
Xiaodi Chen
LXLi Xu
Li Xu
MXMin Xiao
Min Xiao
LLLili Lu
Lili Lu
Gut bacteria provide a rich source of glycosidases that can recognize and/or hydrolyze glycans for nutrition. Interestingly, some glycosidases have also been found to catalyze transglycosylation reactions in vitro and thus can be used for oligosaccharide synthesis. In this work, six putative and one known exo -α-sialidase genes—three from Bacteroides fragilis NCTC9343, three from Clostridium perfringens ATCC 13124, and one known from Bifidobacterium bifidum JCM1254—were subjected to gene cloning and heterogeneous expression in Escherichia coli . The recombinant enzymes were purified, characterized for substrate specificity, and screened for transglycosylation activity. A sialidase, named BfGH33C, from B. fragilis NCTC9343 was found to possess excellent transglycosylation activity for the synthesis of sialylated human milk oligosaccharide. The native BfGH33C was a homodimer with a molecular weight of 113.6 kDa. The K m and k cat values for 4-methylumbelliferyl N -acetyl-α- d -neuraminic acid and sialic acid dimer were determined to be 0.06 mM and 283.2 s −1 , and 0.75 mM and 329.6 s −1 , respectively. The enzyme was able to transfer sialyl from sialic acid dimer or oligomer to lactose with high efficiency and strict α2-6 regioselectivity. The influences of the initial substrate concentration, pH, temperature, and reaction time on transglycosylation were investigated in detail. Using 40 mM sialic acid dimer (or 40 mg/ml oligomer) and 1 M lactose (pH 6.5) at 50°C for 10 min, BfGH33C could specifically produce 6′-sialyllactose, a dominant sialylated human milk oligosaccharide, at a maximal conversion ratio above 20%. It provides a promising alternative to the current chemical and enzymatic methods for obtaining sialylated oligosaccharides. IMPORTANCE Sialylated human milk oligosaccharides are significantly beneficial to the neonate, as they play important roles in supporting resistance to pathogens, gut maturation, immune function, and brain and cognitive development. Therefore, access to the sialylated oligosaccharides has attracted increasing attention both for the study of saccharide functions and for the development of infant formulas that could mimic the nutritional value of human milk. Nevertheless, nine-carbon sialic acids are rather complicated for the traditional chemical modifications, which require multiple protection and deprotection steps to achieve a specific glycosidic bond. Here, the exo -α-sialidase BfGH33C synthesized 6′-sialyllactose in a simple step with high transglycosylation activity and strict regioselectivity. Additionally, it could utilize oligosialic acid, which was newly prepared in an easy, economical way to reduce the substrate cost, as a glycosyl donor. All the studies laid a foundation for the practical use of BfGH33C in large-scale synthesis of sialylated oligosaccharides in the future.